In stock
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog (engineered to mimic a natural fragment) that stimulates the pituitary gland to release endogenous growth hormone in a pulsatile manner. Clinically, it is best known for its FDA-approved use in reducing excess visceral (abdominal) fat in patients with HIV-associated lipodystrophy.
Visceral Fat Reduction: It has a strong clinical track record for targeting metabolically dangerous deep belly fat surrounding the internal organs, generally spares subcutaneous fat and preserves lean muscle mass.
• FDA approved
• 99% Pure
• Independent Lab Tested, Lot Verified
Option
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog (engineered to mimic a natural fragment) that stimulates the pituitary gland to release endogenous growth hormone in a pulsatile manner. Clinically, it is best known for its FDA-approved use in reducing excess visceral (abdominal) fat in patients with HIV-associated lipodystrophy.
Visceral Fat Reduction: It has a strong clinical track record for targeting metabolically dangerous deep belly fat surrounding the internal organs, generally spares subcutaneous fat and preserves lean muscle mass.
• FDA approved
• 99% Pure
• Independent Lab Tested, Lot Verified
Select an option to see this lot’s certification status. We do not publish COA documents online — a copy is emailed on request.
For laboratory research use only. Not for human or animal consumption.